Navigation Links
Heart attack not a death sentence

Survivors of cardiac arrest who received intensive care can expect long-term quality of life at reasonable expense to the health care system. Research published today in BioMed Central's open access journal Critical Care is the first to show that the allocation of resources to the treatment of heart attack patients is equally as justified as the treatment of other intensive care patient groups.

More than 600,000 people in Europe suffer cardiac arrest each year. Following successful CPR, patients are routinely admitted to intensive care units (ICUs). Although ICUs only care for a minority of patients, they consume a large proportion of hospital budgets. The lead author of the study, Juergen Graf from the Philipps-University Marburg, Germany, said, "economic constraints create pressure to ration ICU care. Restricting the demand for futile medical services by limiting access to the ICU, at least for those patients likely to die anyway, has been proposed as a way of lowering expenditures".

In order to investigate this, Graf and his colleagues conducted an assessment of health status of patients five years after discharge from the ICU of Medical Clinic I, University Hospital Aachen, and combined this with a fully costed economic evaluation. Of 354 patients admitted to the ICU with cardiac arrest, 204 died prior to discharge from the hospital. Of the 150 remaining, 40 died before year five, leaving 110 patients (31%) eligible for the survey. The total costs for the ICU treatment of all 354 patients amounted to more than 6.3million euros.

According to Graf, "This is approximately double the cost of an average ICU patient, but it does compare favorably to a variety of other routine interventions such as mechanical ventilation or kidney dialysis". Furthermore, patients who survived cardiac arrest do not necessarily have as bleak a prognosis as is often anticipated. As the authors explain, "The health-related quality of life five years after discharge was only slightly lower than healthy controls of the same age and gender of the patients".

Graf concludes, "Our study is the first to demonstrate that patients who survive cardiac arrest without severe neurological disabilities may expect fair long-term survival and a good quality of life for reasonable expenses to the health care system".


Contact: Graeme Baldwin
BioMed Central

Related medicine news :

1. Decisions under pressure: its all in the heartbeat
2. Stereotaxis Magnetic Navigation System Used to Successfully Treat an Inoperable Congenital Heart Defect in a 10-Year Old Patient
3. Diabetes could be a hidden condition for heart disease patients
4. Arizona Heart Institute Remembers Heart Surgery Pioneer Dr. Michael E. DeBakey
5. Optimism About Heart Risk Pays Off
6. Coronary Heart Disease Not a Cheery Condition
7. Josserand and Gardner to Lead American Heart Association in 2008-09
8. Poor Blood Sugar Control After Heart Surgery Impacts Outcomes
9. Positive thinking is prescription for the heart
10. American Heart Association Saddened by Death of Surgical Pioneer Michael E. DeBakey
11. Beta Blockers Help Hospitalized Heart Failure Patients
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: